Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q4 EPS of ($0.10), $0.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $343 thousand versus the consensus estimate of $290 thousand.

For earnings history and earnings-related data on Lexicon Pharmaceuticals (LXRX) click here.

Earnings